Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stock Market News For September 26, 2016

Published 09/25/2016, 10:10 PM
Updated 07/09/2023, 06:31 AM

Slump in oil prices dragged benchmarks down on Friday. Skepticism that Saudi Arabia will reach an agreement on production limits this week, hammered oil prices. Apple (NASDAQ:AAPL) also weighed on the broader markets amid iPhone sales concerns. A Fed-induced rally, however, helped the major indexes close in the green for the week. Even though the case for a rate hike strengthened, for now the Fed refrained from raising rates.

For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall Street article.

The Dow Jones Industrial Average (DJI) declined 0.7%, to close at 18,261.45. The S&P 500 fell 0.6% to close at 2,164.69. The tech-laden Nasdaq Composite Index closed at 5,305.75, decreasing 0.6%. The fear-gauge CBOE Volatility Index (VIX) gained 2.3% to settle at 12.29. A total of around 3.2 billion shares were traded on Friday on the NYSE. Decliners outpaced advancing stocks on the NYSE. For 66% stocks that declined, 31% advanced.

Oil Slides as OPEC Deal Seems Unlikely

Investor sentiment took a beating on Friday, thanks to a renewed slide in oil prices. Crude dropped after Saudi Arabia said that it doesn’t expect the Organization of the Petroleum Exporting Countries (OPEC) to reach an agreement on output limits, when it meets on Wednesday in Algeria. The group’s general secretary had already said that such a meeting is informal and is not for decision making.

Countries like Saudi Arabia and Iran continue to disagree over oil production limits. Both these countries have an age-old political rivalry and are in a fierce competition when it comes to selling more oil. WTI and Brent crude fell 4.1% and 3.8% to $44.48 per barrel and $45.89 a barrel, respectively.

The Energy Select Sector SPDR (XLE (NYSE:XLE)) decreased 1.3% amid sharp drop in oil prices. Dow components such as Chevron Corporation (NYSE:CVX) (CVX) and Exxon Mobil Corporation (NYSE:XOM) (XOM) dropped 0.8% and 0.1%, respectively. Both these companies possess a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Apple Adds to Woes

Apple Inc. (AAPL) also contributed to the negative sentiment. Shares of the iPhone maker fell 1.7% on Friday after research company GfK raised concerns about sales of the latest iPhone 7 and 7 Plus (read more: Will iPhone 7 Push Apple Back to Bull Market Territory?).

The Gfk report showed that iPhone 7 and 7 Plus sales in Europe fell 25% year-over-year during its launch weekend. Meantime, Digitimes showed that chip orders for iPhone 7 and 7 Plus is expected to decline around 20% sequentially in the first quarter of 2017.

Stocks Notch Weekly Gains

For the week, the Dow, the S&P 500 and the Nasdaq gained 0.8%, 1.2% and 1.2%, respectively. Benchmarks notched weekly gains as investors cheered the Federal Reserve’s latest policy announcement. The Fed opted to keep short-term interest rates unchanged “for the time being” as they sought further evidence of economic strength.

Fed Chairwoman Janet Yellen said that she is in no hurry to raise rates as inflation continued to run below the Fed’s target level of 2%. She also noted that business investment remains soft and wants to see further improvement in the job market. How the markets fare in the upcoming months surrounding the upcoming presidential election is also expected to play a crucial role in determining such moves (read more: Fed Holds Off Rate Hike for Now: Top 5 Gainers).

Stocks that Made Headlines

Salesforce Eyeing Twitter Per Reports, Does it Make Sense?

Twitter Inc. (TWTR) is in talks with several potential buyers and salesforce.com, Inc. (CRM) is one of them. (Read More)

Amgen (NASDAQ:AMGN
)'s Biosimilar of Abbvie's Humira Gets FDA Approval

Amgen, Inc. (AMGN) today announced the approval of Amjevita, a biosimilar version to AbbVie Inc (NYSE:ABBV).’s (ABBV) rheumatoid arthritis drug Humira. (Read More)

T-Mobile US to Buy Spectrum from Charter Communications

T-Mobile US Inc. (TMUS) recently entered into an agreement with Charter Communications Inc (NASDAQ:CHTR). (CHTR) to acquire a license of 700 MHz A Block spectrum for Eastern Montana from the latter. (Read More)

Office Depot to Offload its European Operations to Aurelius

Office Depot, Inc. (ODP) shares gained after the company announced its decision to sell its European operation to The Aurelius Group. (Read More)

CenturyLink (CTL) to Unveil 17-Channel OTT Service in 2017

U.S. telecom operator CenturyLink Inc (NYSE:CTL). (CTL) plans to launch over the top (OTT) services in the beginning of 2017. (Read More)

Where Do Zacks' Investment Ideas Come From?

You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 ""Strong Buy"" stocks free of charge. There is no better place to start your own stock search. Plus you can access the full list of must-avoid Zacks Rank #5 ""Strong Sells"" and other private research. See the stocks free >>



APPLE INC (AAPL): Free Stock Analysis Report

CHEVRON CORP (CVX): Free Stock Analysis Report

EXXON MOBIL CRP (XOM): Free Stock Analysis Report

TWITTER INC (TWTR): Free Stock Analysis Report

SALESFORCE.COM (CRM): Free Stock Analysis Report

AMGEN INC (AMGN): Free Stock Analysis Report

ABBVIE INC (ABBV): Free Stock Analysis Report

T-MOBILE US INC (TMUS): Free Stock Analysis Report

CHARTER COMM-A (CHTR): Free Stock Analysis Report

OFFICE DEPOT (ODP): Free Stock Analysis Report

CENTURYLINK INC (CTL): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.